Valuing health outcomes in cost–effectiveness analyses: health years in total vs QALYs

Researchers have generated a novel framework for valuing health outcomes in cost—effectiveness analyses, termed ‘health years in total’ (HYT), which may allow some of the limitations associated with current best health outcomes measures to be overcome. Published in Value in Health, researchers from the University of Washington (WA, USA) describe a novel framework for valuing health outcomes in cost—effectiveness analyses, using ‘health years in total’ (HYT). It is hoped this new measure will allow some of the limitations associated with the current best health outcomes measures, such as the quality-adjusted life year (QALY) and ‘equal value of life’, to be...